I am a
Home I AM A Search Login

Papers of the Week

2022 Aug 11

Adv Clin Exp Med

Quality of life in patients with lymphoproliferative neoplasms at diagnosis and after the first-line treatment.


The assessment of the quality of life (QoL) in hematology-oncology patients is extremely important. The disease and anti-cancer therapy can cause adverse effects, directly impacting the physical and mental condition of the patient and indirectly influencing their social and professional situation. Therefore, a properly performed QoL assessment should take into account all of these aspects. Moreover, QoL assessment has a prognostic value in regard to treatment success and prognosis; therefore, the improvement in the QoL is often one of the goals of therapy.